Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer.
Valério-Fernandes Â, Fonseca NA, Gonçalves N, Cruz AF, Pereira MI, Gregório AC, Moura V, Ladeirinha AF, Alarcão A, Gonçalves J, Abrunhosa A, Melo JB, Carvalho L, Simões S, Moreira JN.
Valério-Fernandes Â, et al.
Cancers (Basel). 2022 Apr 29;14(9):2217. doi: 10.3390/cancers14092217.
Cancers (Basel). 2022.
PMID: 35565346
Free PMC article.
Notwithstanding the advances in the treatment of lung cancer with immune checkpoint inhibitors, the high percentage of non-responders supports the development of novel anticancer treatments. Herein, the expression of the onco-target nucleolin in patient-derived pulmonary c …
Notwithstanding the advances in the treatment of lung cancer with immune checkpoint inhibitors, the high percentage of non-responders suppor …